NeurAxon raises $14 million in debt funding round - MarketLine Financial Deals

NeurAxon raises $14 million in debt funding round

NeurAxon raises $14 million in debt funding round - MarketLine Financial Deals
NeurAxon raises $14 million in debt funding round
Published Sep 29, 2010
4 pages — Published Sep 29, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

NeurAxon, Inc., a Canadian developer of pain therapeutics focused on the neuronal nitric oxide synthase (nNOS), has raised approximately $14 million through issuing convertible debentures.

  
Source:
Document ID
MA33388_100930
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "NeurAxon raises $14 million in debt funding round" Sep 29, 2010. Alacra Store. Dec 02, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/NeurAxon-raises-14-million-in-debt-funding-round-2052-44259>
  
APA:
MarketLine Financial Deals. (2010). NeurAxon raises $14 million in debt funding round Sep 29, 2010. New York, NY: Alacra Store. Retrieved Dec 02, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/NeurAxon-raises-14-million-in-debt-funding-round-2052-44259>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.